IMMU-16. ANTI-VEGF TREATMENT EFFECT AGAINST GLIOMA IS IMMUNE DEPENDENT AND MEDIATED BY ENHANCED T CELL ACTIVITYCécile L. Maire, Katrin Lamszus, Malik Alawi et al.|Neuro-Oncology|2024Cited by 1
IMMU-20. MODULATION OF THE PERIPHERAL T CELL BIOLOGY IN GLIOBLASTOMAMalte Mohme, Katrin Lamszus, Alessandra Rünger et al.|Neuro-Oncology|2022Cited by 0
P12.01.B ANTI-VEGF TREATMENT EFFECT AGAINST GLIOMA IS IMMUNE DEPENDENT AND MEDIATED BY ENHANCED T CELL ACTIVITYCécile L. Maire, K Lamszus, Monika Westphal et al.|Neuro-Oncology|2024Cited by 0